Immunological and biochemical studies and pilot therapeutic trial with ubidecarenone in Kearns-Sayre patients.
Bresolin
N
N
Institute of Clinical Neurology, University of Milan, Italy.
Bet
L
L
Ferrante
C
C
Binda
A
A
Carenzi
A
A
Moggio
M
M
Comi
G
G
Scarlato
G
G
D003067:Coenzymes; D004341:Drug Evaluation; D004579:Electron Transport; D006321:Heart / Q000503:physiopathology; D006801:Humans; D007625:Kearns-Sayre Syndrome / Q000097:blood / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D008931:Mitochondria, Muscle / Q000187:drug effects / Q000378:metabolism; D009132:Muscles / Q000503:physiopathology; D009886:Ophthalmoplegia / Q000188:drug therapy*; D010865:Pilot Projects; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000627:therapeutic use
D003067:Coenzymes; D014451:Ubiquinone; C024989:coenzyme Q10